Mutations of NR3C1 have been described in glucocorticoid resistance syndrome in association with bilateral adrenal hyperplasia [49]; Next Genome Sequencing studies have then found rare loss-of-function NR3C1 mutations in ACTH-secreting adenomas [50]. This evidence concerns the gene POMC and adenoma.